ALS Center Celebrates Opening of New Practice Office

Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center recently celebrated the opening of the ALS Center’s new office in the Dr. Robert H. Harris Neuroscience Treatment Center. The center is one of only two Certified Treatment Centers of Excellence in New Jersey and is designated by the ALS Association’s National Office and the Greater Philadelphia Chapter.

UT Southwestern ranked top health care institution globally for published research by Nature Index

For the third year in a row, UT Southwestern is ranked as the top health care institution globally by Nature Index for publishing high-quality research in all subjects and in the life sciences.

RUSH, Franciscan to Partner on Clinical Services for Cancer, Neurosciences

Chicago-based Rush University System for Health and Franciscan Alliance, Inc., are partnering to jointly develop and provide clinical services to improve the availability of health care to patients in Northwest Indiana, giving patients streamlined access to subspecialty care in their own communities.

Mayo Clinic expert provides tips for reducing dementia risk

More than 55 million people worldwide are believed to be living with dementia, according to the World Health Organization. Ronald Petersen, M.D., a neurologist and director of Mayo Clinic’s Alzheimer’s Disease Research Center, says you can’t prevent dementia, but you can reduce your risk.

Baylor Scott & White Health Again Recognized as Most Awarded Not-for-profit Health System in Texas by U.S. News & World Report

In the midst of the extraordinary health challenge presented by the COVID-19 pandemic, Baylor Scott & White Health remains committed to quality, safe care and helping Texas communities navigate the uncertainty of the SARS-CoV-2 virus. Today, this commitment to safety and quality is recognized as U.S. News & World Report releases its 2020-2021 Best Hospitals list.

Current Clinical Trial Assessing Potential of CBD in Treatment of Autism

Researchers at University of California San Diego School of Medicine are recruiting eligible children between the ages of seven and fourteen years for a Phase III clinical trial to determine whether cannabidiol (CBD) reduces severe behavior problems in children with autism spectrum disorder.

Multi-sensor Band Quickly and Simply Records Subtle Changes in Patients with MS

An international team of scientists, led by UC San Diego researchers, has developed a new, multi-sensor tool that measures subtle changes in multiple sclerosis patients, allowing physicians to more frequently and more quickly respond to changes in symptoms or patient condition.